Human leptin: From an adipocyte hormone to an endocrine mediator

European Journal of Endocrinology

Volumn 143, Issue 3, 2000, Pages 293-311

  Wauters, M ^a   Considine, R V ^a   Van Gaal, L F ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; SEX HORMONE; TESTOSTERONE; THYROID HORMONE;

ADIPOCYTE; BODY WEIGHT; ENDOCRINE SYSTEM; FOOD INTAKE; GLUCOSE METABOLISM; HEMATOPOIESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNE SYSTEM; NEUROENDOCRINE SYSTEM; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; REPRODUCTION; REVIEW; SEXUAL MATURATION;

EID: 0033794850     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430293     Document Type: Review

References (274)

1. Positional cloning of the mouse obese gene and its human homologue
2. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
3. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects
4. Increased obese mRNA expression in omental fat cells from massively obese humans
5. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
6. The role of depot fat in the hypothalamic control of food intake in the rat
7. Effects of parabiosis of obese with diabetes and normal mice
8. Human Obese gene expression - Adipocyte-specific expression and regional differences in the adipose tissue
9. Effects of the obese gene product on body weight regulation in ob/ob mice
10. Weight-reducing effects of the plasma protein encoded by the obese gene
11. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
12. Identification and expression cloning of a leptin receptor, OB-R
13. Identification of leptin action in rat hypothalamus
14. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
15. The role of neuropeptide Y in the antiobesity action of the obese gene product
16. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity
17. Mutation screening and identification of a sequence variation in the human OB gene coding region
18. Absence of mutations in the human OB gene in obese/diabetic subjects
19. Human obese gene: Molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity
20. Molecular screening of both the promoter and the protein coding regions in the human ob gene in Japanese obese subjects with non-insulin-dependent diabetes mellitus
21. Congenital leptin deficiency is associated with severe early-onset obesity in humans
22. A leptin missense mutation associated with hypogonadism and morbid obesity
23. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
24. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
25. Leptin: The tale of an obesity gene
26. The hypothalamic leptin receptor in humans: Identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations
27. Leptin receptor gene in a large cohort of massively obese subjects: No indication of the fa/fa rat mutation. Detection of an intronic variant with no association with obesity
28. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
29. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians
30. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR)
31. Amino acid variants in the human leptin receptor: Lack of association to juvenile onset obesity
32. Human leptin receptor gene in obese Japanese subjects: Evidence against either obesity-causing mutations or association of sequence variants with obesity
33. Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families
34. The GIn223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity
35. Leptin receptor gene variation and obesity: Lack of association in a white British male population
36. Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study
37. Associations between leptin receptor gene polymorphisms obesity-related phenotypes in obese women
38. A preliminary meta-analysis of the association of LEPR polymorphisms with anthropometric variables
39. Evidence of free and bound leptin in human circulation - Studies in lean and obese subjects and during short-term fasting
40. Leptin enters the brain by a saturable system independent of insulin
41. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
42. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
43. Diet-induced obese mice develop peripheral but not central, resistance to leptin
44. From lesions to leptin: Hypothalamic control of food intake and body weight
45. Leptin and the hypothalamic-pituitary-adrenal axis activity in women with different obesity phenotypes
46. Plasma leptin in non-diabetic Asian Indians: Association with abdominal adiposity
47. Are leptin levels dependent on body fat distribution in obese men and women?
48. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans
49. Depotand sex-specific differences in human leptin mRNA expression
50. Depot-specific differences in adipose tissue gene expression in lean and obese subjects
51. Plasma leptin and insulin relationships in obese and nonobese humans
52. Gender differences in plasma leptin concentrations
53. Effects of gender, body composition and menopause on plasma concentrations of leptin
54. Sexual dimorphism in plasma leptin concentration
55. Plasma leptin concentrations: Gender differences and associations with metabolic risk factors for cardiovascular disease
56. Sex-based differences in serum leptin concentrations from umbilical cord blood at delivery
57. Placental leptin: An important new growth factor in intrauterine and neonatal development?
58. Serum leptin concentration in cord blood: Relationship to birth weight and gender
59. Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones and pubertal stage
60. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone
61. Leptin serum levels in normal weight and obese children and adolescents: Relationship with age, sex, pubertal development, body mass index, and insulin
62. Gender differences in leptin levels during puberty are related to the subcutaneous fat depot and sex steroids
63. Contribution of androgens to the gender difference in leptin production in obese children and adolescents
64. Circulating leptin in normal children and during the dynamic phase of juvenile obesity. Relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism
65. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: Dexamethasone and estradiol stimulate leptin release in women, but not in men
66. Leptin in human pregnancy: The relationship with gestational hormones
67. Regulation of leptin by steroid hormones in rat adipose tissue
68. Estrogen increases in vivo leptin production in rats and human subjects
69. Relationship between leptin and oestrogens in healthy women
70. Serum and follicular fluid leptin during in vitro fertilization: Relationship among leptin increase, body fat mass, and reduced ovarian response
71. Effects of exogenous gonadal steroids on leptin homeostasis in rats
72. Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men
73. The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty
74. Strong association between serum levels of leptin and testosterone in men
75. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men
76. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals
77. Leptin concentrations, sex hormones, and cortisol in non-diabetic men
78. The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF-I/IGF-BP system, dehydroepiandrosterone, androstenedione and testosterone in an elderly population
79. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: Pulsatile and diurnal patterns of circulating gonadotropins
80. Menstrual cycles: Fatness as a determinant of minimum weight for height necessary for their maintenance or onset
81. Plasma concentrations of obese protein in anorexia nervosa
82. Serum leptin levels in women with anorexia nervosa
83. Hypoleptinemia in women athletes: Absence of a diurnal rhythm with amenorrhea
84. Role of leptin in hypothalamic-pituitary function
85. Hypothalamic control of FSH and LH by FSH-RF, LHRH, cytokines, leptin and nitric oxide
86. Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role for leptin on pituitary cell proliferation
87. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction
88. The expression of leptin and its receptors in pre-ovulatory human follicles
89. Expression of functional leptin receptors in the human ovary
90. Direct intraovarian effects of leptin: Impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17β production by rat ovarian granulosa cells
91. Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary
92. Adipose obese gone product, leptin, inhibits bovine ovarian thecal cell steroidogenesis
93. Leptin modulates the glucocorticoid-induced ovarian steroidogenesis
94. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin
95. Leptin treatment rescues the sterility of genetically obese ob/ob males
96. Leptin is a metabolic signal to the reproductive system
97. Influence of endogenous leptin tone on the estrous cycle and luteinizing hormone pulsatility in female rats
98. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding; implications for energy homeostasis and neuroendocrine function
99. Leptin accelerates the onset of puberty in normal female mice
100. Early onset of reproductive function in normal female mice treated with leptin
101. Role of leptin in the neuroendocrine response to fasting
102. Leptin is a metabolic gate for the onset of puberty in the female rat
103. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
104. Nocturnal rise of leptin in normal prepubertal and pubertal children and in patients with perinatal stalk-transection syndrome
105. Diurnal variation of the serum leptin concentration in patients with anorexia nervosa
106. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty
107. Leptin binding activity changes with age: The link between leptin and puberty
108. Circulating leptin in women: A longitudinal study in the menstrual cycle and during pregnancy
109. Changes in plasma leptin during the menstrual cycle
110. Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle
111. Serum leptin concentrations during the menstrual cycle in normal-weight women: Effects of an oral triphasic estrogen-progestin medication
112. Correlation between circulating leptin and luteinizing hormone during menstrual cycle in normal weight women
113. Synchronicity of frequently sampled, 24 h concentrations of circulating leptin luteinizing hormone, and estradiol in healthy women
114. Serum leptin concentration in women: Effect of age, obesity, and estrogen administration
115. Leptin in human reproduction: Serum leptin levels in pregnant and lactating women
116. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: Relation to neonatal and placental weight
117. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy
118. Plasma leptin influences gestational weight gain and postpartum weight retention
119. Changes of maternal serum leptin levels during pregnancy
120. Serum leptin concentrations during pregnancy and their relationship to fetal growth
121. Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies
122. Hyperleptinemia of pregnancy is associated with the appearance of a circulating form of the leptin receptor
123. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
124. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta
125. Serum immunoreactive leptin concentrations in women with Polycystic Ovary Syndrome
126. Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels
127. Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome
128. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome
129. Leptin concentrations in the Polycystic Ovary Syndrome
130. Serum leptin levels in women with polycystic ovary syndrome: The role of insulin resistance/hyperinsulinemia
131. Serum leptin concentrations in women with Polycystic Ovary Syndrome
132. Circulating leptin concentrations in polycystic ovary syndrome: Relation to anthropometric and metabolic parameters
133. Leptin is normal in PCOS - An editorial about three 'negative' papers
134. Leptin concentrations in women in the San Antonio Heart Study: Effect of menopausal status and postmenopausal Hormone Replacement Therapy
135. Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans
136. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy in older women
137. Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat
138. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: Its relationships with body fat, visceral adiposity, and age in women
139. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms
140. UKPDS 20: Plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects
141. Transient increase in obese gene expression after food intake or insulin administration
142. Regulation of ob gene mRNA levels in cultured adipocytes
143. Acute and chronic effect of insulin on leptin production in humans - Studies in vivo and in vitro
144. Insulin and cortisol promote leptin production in cultured human fat cells
145. Regulation of leptin production in cultured mature white adipocytes
146. Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes
147. The ob gene and insulin: A relationship leading to clues to the understanding of obesity
148. Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA
149. Increase in plasma leptin and Lep mRNA concentrations by food intake is dependent on insulin
150. Plasma leptin in diabetic and insulin-treated diabetic and normal rats
151. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
152. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects
153. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects
154. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women
155. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue
156. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects
157. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity
158. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy
159. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice
160. Acute and chronic effects of leptin on glucose utilization in lean mice
161. Effects of leptin on insulin sensitivity in normal rats
162. Leptin affects pancreatic endocrine functions through the sympathetic nervous system
163. Pleiotropic cellular effects of leptin
164. Leptin receptors expressed on pancreatic β-cells
165. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion
166. + channels in pancreatic β-cells
167. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice
168. Leptin inhibits insulin secretion and reduces insulin mRNA levels in rat isolated pancreatic islets
169. Leptin: A potent inhibitor of insulin secretion
170. Effects of leptin on insulin secretion from isolated rat pancreatic islets
171. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B
172. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus
173. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1
174. Persistently enhanced sensitivity of pancreatic islets from ob/ob mice to PKC-stimulated insulin secretion
175. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans
176. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice
177. Acute stimulation of glucose metabolism in mice by leptin treatment
178. β-Cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy
179. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat
180. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action
181. Specificity of leptin action on elevated blood glucose levels and hypothalamic Neuropeptide Y gene expression in ob/ob mice
182. Modulation of insulin activities by leptin
183. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action
184. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes
185. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
186. Leptin increases basal and insulin-stimulated glucose uptake into human subcutaneous adipocytes
187. Transcriptional regulation of fatty acid synthase gene by insulin/glucose, polyunsaturated fatty acid and leptin in hepatocytes and adipocytes in normal and genetically obese rats
188. 12 myotubes: Evidence for a PI3-kinase mediated effect
189. 12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
190. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: Evidence for an effect of leptin on glucose uptake and decarboxylation
191. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice
192. Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes
193. Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro
194. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells
195. Leptin does not affect adipocyte glucose metabolism: Studies in fresh and cultured adipocytes
196. Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice
197. Leptin: Is it important in diabetes?
198. Does leptin contribute to diabetes caused by obesity?
199. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
200. Morphologic and molecular changes induced by recombinant human leptin in the white and brown adipose tissues of C57BL/6 mice
201. Leptin concentrations in diabetic and nondiabetic Mexican-Americans
202. Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects
203. Hyperleptinaemia: The missing link in the Metabolic Syndrome?
204. Plasma leptin and acute serotoninergic stimulation of the corticotropic axis in women who are normal weight or obese
205. Decreased central and peripheral catecholaminergic activation in obese Zucker rats
206. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress
207. Expression of Ob receptor in normal human adrenals: Differential regulation of adrenocortical and adrenomedullary function by leptin
208. Leptin directly stimulate catecholamine secretion and synthesis in cultured porcine adrenal medullary chromaffin cells
209. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Leptin inhibits cortisol release directly
210. Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland
211. Leptin down-regulates the steroid producing system in the adrenal
212. Dexamethasone regulates obese expression in isolated rat adipocytes
213. Regulation of expression of ob mRNA and protein by glucocorticoids and cAME
214. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake
215. Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat
216. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women
217. Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man
218. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects
219. High leptin concentrations in serum of very obese children are further stimulated by dexamethasone
220. Dexamethasone increases leptin expression in humans in vivo
221. Robust leptin secretory responses to dexamethasone in obese subjects
222. Dexamethasone, OB gene, and leptin in humans; effect of exogenous hyperinsulinemia
223. Obesity results as a consequence of glucocorticoid induced leptin resistance
224. Serum immunoreactive leptin levels are increased in patients with Cushing's syndrome
225. Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome
226. Determinants of serum leptin levels in Cushing's syndrome
227. Glucocorticoids as counterregulatory hormones of leptin. Towards an understanding of leptin resistance
228. Neuropeptide-Y-immuno-reactive innervation of thyrotropin-releasing hormone-synthesizing neuron in the rat hypothalamic paraventricular nucleus
229. Reciprocal synaptic relations between CRF-immunoreactive and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus
230. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus
231. Expression of leptin and beta 3-adrenergic receptors in rat adipose tissue in altered thyroid states
232. Thyroid hormones influence serum leptin concentrations in the rat
233. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes
234. Short-term hyperthyroidism has no effect on leptin levels in man
235. The effects of thyroid status on plasma leptin levels in women
236. Leptin and the pituitary-thyroid axis; a comparative study in lean, obese, hypothyroid and hyperthyroid subjects
237. Influence of thyroid status on serum immunoreactive leptin levels
238. Serum leptin concentrations in patients with thyroid disorders
239. Serum leptin levels in hypo- and hyperthyroidism
240. The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects
241. Thyroid dysfunction is not associated with alterations in serum leptin levels
242. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations
243. Role of thyroid hormones on serum leptin levels
244. Growth hormone in obesity
245. Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men
246. Clinical aspects of growth hormone deficiency in adults
247. Threading analysis suggest that the obese gene product may be a helical cytokine
248. Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone
249. Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels
250. Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion
251. The in vitro effect of leptin on basal and growth hormone-releasing hormone-stimulated growth hormone secretion from the ovine pituitary gland
252. Upregulation of leptin receptor gene expression in the anterior pituitary of human growth hormone-releasing hormone transgenic mice
253. Leptin alters the response of the growth hormone releasing factor-growth hormone-insulin-like growth factor-I axis to fasting
254. Leptin regulates GH secretion in the rat by acting on GHRH and somatostatinergic functions
255. Regulation of in vivo growth hormone secretion by leptin
256. Leptin increases in vivo GH responses to GHRH and GHRP-6 in food-deprived rats
257. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects
258. Circulating leptin level and growth hormone response to stimulation tests in obese and normal children
259. The relationship between growth hormone kinetics and sarcopenia in postmenopansal women: The role of fat mass and leptin
260. Serum insulin but not leptin is associated with spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in normal volunteers with and without weight loss
261. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF-I) in normal rats
262. Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency
263. Differential effects of growth hormone and prednisolone on energy metabolism and leptin levels in humans
264. Serum leptin levels and leptin expression in growth hormone (GH)-deficient and healthy adults: Influence of GH treatment, gender, and fasting
265. Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men
266. Isoproterenol and somatostatin decrease plasma leptin in humans: A novel mechanism regulating leptin secretion
267. Serum leptin is increased in growth hormone-deficient adults: Relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year
268. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults
269. Serum leptin concentrations in a normal population and in GH deficiency: Negative correlation with testosterone in men and effects of GH treatment
270. Increased levels but preserved diurnal variation of serum leptin in GH-deficient patients: Lack of impact of different modes of GH administration
271. The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults
272. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men
273. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency
274. Serum leptin levels during recombinant human GH therapy in adults with GH deficiency